Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - indapamide hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; colloidal anhydrous silica; hypromellose; macrogol 3350; titanium dioxide; purified talc; polyvinyl alcohol - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, indapamide is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate -

United States - English - NLM (National Library of Medicine)

rebel distributors corp - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions below). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions below). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities and use of support ho

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; calcium carbonate; maize starch; povidone; acacia; sucrose; purified talc; lactose monohydrate; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 2.5 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions below). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions below). dependent edema in pregnancy, resulting from restriction of ve

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. usage in pregnancy: the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions below). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions below). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities

United States - English - NLM (National Library of Medicine)

avkare - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. usage in pregnancy: the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities